|Bid||2.0300 x 0|
|Ask||2.0500 x 0|
|Day's Range||2.0000 - 2.1000|
|52 Week Range||1.9700 - 6.0600|
|Beta (5Y Monthly)||1.76|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar. 03, 2022 - Mar. 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.79|
Oncolytics Biotech (ONCY) has been struggling lately, but the selling pressure may be coming to an end soon.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Oncolytics Biotech Inc. (ONCY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.